New Products

DEERFIELD, Ill. — Lundbeck announced today that Onfi (clobazam) CIV will be available in scored tablet and oral suspension formulations beginning this week after the formulations were recently approved by the U.S. Food and Drug Administration. Onfi is a prescription medication originally approved by the FDA in 2011, and is used along with other medicines to treat seizures associated with Lennox-Gastaut syndrome (LGS) in adults and children 2 years of age or older. Onfi is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine.

WASHINGTON — The U.S. Food and Drug Administration on Monday approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection that is manufactured by GlaxoSmithKline.

Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply. It is a pill taken daily in combination with other antiretroviral drugs.

ARLINGTON, Va. — Electronic prescribing network Surescripts has added 19 state health information exchanges and health information service providers to its network, the company said.

These include entities in Maryland, Ohio, Colorado, Michigan, New York, Tennessee and others.

SOUTH DEERFIELD, Mass. — Collegiate Licensing Company, LLC, an affiliate of IMG College, and the Yankee Candle Company Inc., today announced the launch of a new co-branded collegiate-themed candle line. The Fan Candle Collegiate Collection, which debuted July 8, features 23 CLC institutions including Alabama, Arkansas, Auburn, Boston College, Florida, Florida State, Georgia, Illinois, Kentucky, LSU, Ole Miss, Missouri, North Carolina, Notre Dame, Oklahoma, South Carolina, Tennessee, Texas A&M, Texas, Virginia, Virginia Tech, West Virginia, and Wisconsin.

STOCKHOLM, Sweden — Moberg Pharma AB today announced its U.S. launch of Kerasal NeuroCream, an over-the-counter pain relieving foot cream. This new product will be sold in over 3,800 Walmart stores and in CVS, Walgreens, and Rite Aid drug stores starting late August.

NEWARK, N.J. — Inergetics, a developer of nutraceuticals and nutritional supplements, is proud to announce that Martha Stewart will be in attendance at the National Association of Chain Drug Stores Total Store Expo  at the Sands Expo and Convention Center in Las Vegas on Monday, August 12. Stewart is appearing to support the partnership between Martha Stewart Living Omnimedia and Inergetics, Inc.

PRINCETON, N.J. — Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported that it has made an initial shipment of its first honey-based over-the-counter product to a leading U.S.-based pharmacy chain. This private-label dressing is based on the Medihoney HCS dressing, which is an ideal dressing for dry to lightly exuding wounds including minor burns, cuts and abrasions. The dressing is expected to be on the shelves in more than 4,000 stores by the end of September.

JERUSALEM and ALLEGAN, Mich. — Teva Pharmaceutical Industries Ltd., and Perrigo Co. today announced the launch of the generic equivalent to Temodar (temozolomide). Teva will manufacture, market and distribute the product in the United States, and both companies will equally share in the cost and profitability of the product in the country. Teva was first to file, making the product eligible for 180 days of marketing exclusivity.